Opting for the GR-3 involves working with Fourier Intelligence, a Chinese robotics company that started in the rehabilitation space and still sells mostly to universities and other academic customers.
Launched in 2015 out of Shanghai, China, Fourier Intelligence began as a vendor of rehab exos for clinical rehab and rehab recovery. It is that rehab pedigree that gives Fourier’s general purpose humanoid program the force-controlled actuators, shared space safety, and medical engineering know-how that underpin it. Their humanoid platform families include GR-1, GR-2, GR-3, and the N1. Each iteration narrows the research-customer capability window around the platform. GR-3 is Fourier’s flagship for 2026, with DoF architecture customization, plus all the research-customer SDK goodness. Its customer list for research includes the usual academic robotics programs, rehab research institutions, and advanced engineering outfits worldwide.